Skye Bioscience, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Skye Bioscience, Inc. (SKYE) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $7.22 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-14
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $7.22M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $9.62M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $10.28M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $12.20M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $7.22M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $9.62M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $10.28M 10-K · filed 2026-03-10 |
| 2025-09-30 | $12.20M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $13.71M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $15.03M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $14.73M 10-K · filed 2025-03-20 |
| 2023-12-31 | $3.96M 10-K · filed 2024-03-22 |
| 2022-12-31 | $964.85K 10-K · filed 2023-03-31 |
| 2022-03-31 | $1.43M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $1.65M 10-K · filed 2022-03-28 |
| 2021-09-30 | $860.99K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $764.80K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $750.47K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $688.41K 10-K · filed 2021-03-02 |
| 2020-09-30 | $879.63K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $164.80K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $248.26K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $312.40K 10-K · filed 2020-03-23 |
| 2019-09-30 | $478.44K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $404.30K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $577.12K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $748.62K 10-K · filed 2019-03-14 |
| 2018-09-30 | $547.45K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $678.51K 10-Q · filed 2018-08-10 |
| 2017-12-31 | $677.24K 10-K · filed 2018-03-19 |
| 2017-09-30 | $1.05M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $850.33K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $936.87K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $1.02M 10-K · filed 2017-03-10 |
| 2016-09-30 | $1.11M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.21M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $1.30M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $1.39M 10-K · filed 2016-03-21 |
| 2015-09-30 | $1.48M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $2.15M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $2.18M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $2.08M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |